MedPath

The Effect of Pharmacist Intervention on Blood Pressure Control

Not Applicable
Conditions
Hypertension
Interventions
Behavioral: Health education, Home blood pressure monitoring
Registration Number
NCT01233193
Lead Sponsor
Universidad de Granada
Brief Summary

The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.

Detailed Description

Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.

Exclusion criteria:

  • Patient living with an other Hypertensive patient treated with the same medications
  • Pregnant women
  • Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg
  • Patient with secondary hypertension, kidney or liver failure
  • Patients already included in a care program for hypertensive patients
  • Patients with a new treatment for hypertension (less than 1 month)
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
InterventionHealth education, Home blood pressure monitoringThe intervention group receive an pharmacist intervention (health education, Home Blood Pressure Monitoring and Referral to physician as needed) This group will be followed for 6 months
Primary Outcome Measures
NameTimeMethod
blood pressure controlAt 6 months

Percentage of patients with controlled hypertension

Secondary Outcome Measures
NameTimeMethod
AdherenceAt 6 months

Percentage of adherent patients after 6 months within the trial

Trial Locations

Locations (1)

Community Pharmacies

🇪🇸

Jaén, Andalucia, Spain

© Copyright 2025. All Rights Reserved by MedPath